When medication is appropriate, NICE recommends single-agent therapy with drugs licensed in the UK, such as orlistat (a lipase inhibitor) or, more recently, GLP-1 receptor agonists like semaglutide for eligible patients
Whether Zepbound or Wegovy, we provide personalized guidance and support to ensure safe, effective, and sustainable weight management
STEP 5 trial participants who continued through the plateau maintained their weight loss at 104 weeks
This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Whilst vision problems are not amongst the most commonly reported adverse effects, changes in vision have been documented in clinical trials and post-marketing surveillance
Hims & Hers has a clear growth roadmap, "leveraging both organic growth and strategic investments to expand category leadership and global reach," executives said